Insider track record
OtherAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Ogden Christopher. Officer active across 1 company, notably CytomX Therapeutics, Inc.. Cumulatively, 10 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €14k. Activity tracked since 2 February 2023. The latest transaction was filed on 18 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
8,551 shares@ US$0.59933.9% of flowCommon StockSEC:0001610717-25-000085:0
44,000 shares0Common StockSEC:0001610717-25-000017:0
6,875 shares0Common StockSEC:0001610717-24-000433:0
17,500 shares0Common StockSEC:0001610717-24-000339:0
2,971 shares@ US$2.085541.1% of flowCommon StockSEC:0001610717-24-000177:0
40,000 shares0Common StockSEC:0001610717-24-000034:0
1,990 shares@ US$1.380618.1% of flowCommon StockSEC:0001610717-23-000419:0
6,875 shares0Common StockSEC:0001610717-23-000412:0
516 shares@ US$1.97937.0% of flowCommon StockSEC:0001140361-23-012619:0
25,000 shares0Common StockSEC:0001567619-23-001927:0